The Impact of Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinoma: A Single Center Experience
Not Applicable
Completed
- Conditions
- Hepatocellular carcinomaBCLC stage CHepatocellular carcinomaBCLC stage CTACETransarterial Chemoembolization
- Registration Number
- TCTR20150221001
- Lead Sponsor
- Rajavithi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
1. Advanced HCC patients (BCLC stage C) who received TACE
Exclusion Criteria
Child-Pugh score C
Patients received chemotherapy
Patients received radiation therapy
Patients had surgery before TACE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method median survival time 1 year after intervention Kaplan-Meier method
- Secondary Outcome Measures
Name Time Method Procedural related complication 30 day after intervention Percentage